Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia

Haematologica

Volumn 84, Issue 3, 1999, Pages 208-211

  Molica, Stefano ^a   Vitelli, Gaetano ^b   Levato, Domenico ^a   Levato, Luciano ^a   Dattilo, Angela ^a   Gandolfo, Giuseppe Maria ^b  

^a PUGLIESE CIACCIO HOSPITAL   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Apoptosis; B CLL; Disease progression; IL 8

Indexed keywords

INTERLEUKIN 8;

ADULT; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; BLOOD LEVEL; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS;

APOPTOSIS; BETA 2-MICROGLOBULIN; BONE MARROW; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-8; LEUKEMIA, B-CELL, CHRONIC; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, IGE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0032847538     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dancescu M, Rubio-Tujillo M, Biron G, et al. Interleukin 4 protects chronic lymphocytic leukemia B cells from death by apoptosis and upregulates bcl-2 expression. J Exp Med 1992; 176:1319-24.
2. Panayiotidis P, Ganeshaguru K, Jabbar SAB, Hoffbrand AV. Interleukin 4 inhibits apoptotic cell death and loss of bcl-2 protein in B-cell chronic lymphocytic leukaemia cells in vitro. Br J Haematol 1993; 85:39-45.
3. Di Celle PF, Carbone A, Marchis D, et al. Cytokine expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8(IL-8)mRNA expression and secretion of biologically active IL-8 protein. Blood 1994; 84:220-8.
4. Di Celle PF, Mariani S, Riera L, et al. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996; 87:4382-9.
5. Cheson BD, Bennett JM, Grever M, et. al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87:4990-7.
6. Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48:198-206.
7. Rozman C, Montserrat E, Rodriguez-Fernandez JM, et al. Bone marrow histologic pattern. The best single prognostic parameter in chronic lymphocytic leukemia: a multivariate survival analysis of 329 cases. Blood 1984; 64:642-8.
8. - B-cell lymphoid chronic leukemias. Haematologica 1997; 82:559.
9. Buschle M, Campana D, Carding S R, et al. Interferon-γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J Exp Med 1993; 177:213-9.
10. Fluckiger A C, Durand I, Bancherau J. Interleukin-10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J Exp Med 1994; 179:91-7.
11. Yang E, Korsmeyer S J. Molecular thanaptosis: a discourse on the bcl-2 family and cell death. Blood 1996; 88:386-401.
12. Molica S. Prognostic value of biological variables in B-cell chronic lymphocytic leukemia. Can we improve upon clinical parameters? Haematologica 1997; 82: 705-9.
13. Montserrat E. Chronic lymphoproliferative disorders. Curr Opin Oncol 1997; 9:34-41.
14. Hallek M, Kuhn-Hallek I, Emmerich B. Prognostic factors in chronic lymphocytic leukemia. Leukemia 1997; 11 (suppl 2):4-13.
15. Zachariae COC, Thestrup-Pedersen K, Matsushima K. Expression and secretion of leukocyte chemotactic cytokines by normal human melanocytes and melanoma cells. J Invest Dermatol 1991; 97:593-8.
16. Robertson LE, Plunkett W, Mc Connell K, et al. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with induction of apoptosis and clinical outcome. Leukemia 1996; 10:456-9.
17. Mapara MY, Bommert K, Bargou R, et al. Prognostic significance of bcl-2 expression in chronic lymphocytic leukemia. Blood 1997;90(Suppl 1):91a.
18. Pepper C, Bentley P, Hoy T. Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukamia. Br J Haematol 1996; 95:513-7.
19. Aguilar-Santelises M, Rottenberg ME, Lewin N, et al. Bcl-2, bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression. Int J Cancer (Pred Oncol) 1996; 69:114-9.
20. Matsushima K, Oppenheim JJ. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1989; 1:2-9.